Why the French did not choose to panic: a dynamic analysis of the public response to the influenza pandemic
Why the French did not choose to panic: a dynamic analysis of the public response to the influenza pandemic
复制标题
DOI：
10.1111/j.1467-9566.2012.01525.x
复制
发表时间：
2013-02-01
影响因子：
2.9
通讯作者：
Raude, Jocelyn
中科院分区：
文献类型：
--
作者：
Sherlaw, William;Raude, Jocelyn
为了了解法国公众对2009年甲型H1N1流感健康威胁的反应，采用了序列分析框架，调动了不同的理论链，如创新扩散理论，惊喜理论和社会表征理论。这些往往表明，疾病发作，公共卫生政策和公众的反应，应考虑在一个更大的社会认知框架内，包括由以前的疾病发作和运动锚定的陈述。这篇文章中建议，公众的反应是极大地影响了普遍锚定的社会表征的流行病威胁到1918年西班牙流感在外行和科学媒体。这些陈述最终被认为与疾病的实际情况不符，因此法国公众在2009年大流行期间没有恐慌。这一假设已经通过回顾性媒体、文献资料和通过大流行之前、期间和疫苗接种运动启动后一个月的三项横断面研究进行的风险认知分析进行了实证检验。这些发现表明，对健康威胁的危言耸听可能会适得其反，因为它们可能会降低公共卫生组织在更严重的新发疾病情况下动员公众的能力。
To understand the French public's response to the 2009 pandemic A/H1N1 influenza health threat a sequence analysis framework has been employed mobilising different theoretical strands such as innovations diffusion theory, surprise theory and social representation theory. These tend to suggest that disease episodes, public health policy and the public's response should be considered within a larger socio-cognitive frame incorporating representations anchored by prior disease episodes and campaigns. It is suggested in this article that the public's response was greatly influenced by the pervasive anchoring of the social representations of the pandemic threat to the 1918 Spanish flu in the lay and scientific media. These representations were eventually seen not to match the reality of the disease and consequently the French public did not panic during the 2009 pandemic. This hypothesis has been tested empirically by examining retrospective media, bibliographical data and an analysis of risk perception carried out through three cross-sectional studies prior to and during the pandemic episode and onemonth after the launch of the vaccination campaign. These findings suggest that alarmist framings of health threats may be counterproductive since they may reduce the capacity of public health organisations to mobilise the public in the case of more serious emerging disease.